Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Poulakaki, Nikiforita; Makris, Georgios-Marios; Battista, Marco-Johannes et al.
Hormonal receptor status, Ki-67 and HER2 expression: Prognostic value in the recurrence of ductal carcinoma in situ of the breast?BREAST. Bd. 25. 2016 S. 57-61
Almstedt, Katrin; Schmidt, Marcus
Immunotherapies for Breast Cancer - How Immune System and Cancer are associated and on what the Research works?GEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 76. H. 5. 2016 S. 503-506
Radosa, J. C.; Radosa, C. G.; Kastl, C. et al.
Influence of the Preoperative Decision-Making Process on the Postoperative Outcome after Hysterectomy for Benign Uterine PathologiesGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 76. H. 4. 2016 S. 383-389
Schmidt, Marcus; Thomssen, Christoph; Untch, Michael
Intrinsic Subtypes of Primary Breast Cancer - Gene Expression AnalysisONCOLOGY RESEARCH AND TREATMENT. Bd. 39. H. 3. 2016 S. 102-110
Battista, M. J.; Almstedt, K.; Heimes, A-S. et al.
Management of recurrent and metastatic endometrial cancer in Germany: Results of the nationwide AGO pattern of care studies from the years 2013, 2009 and 2006ONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 98-98
Heller, M.; Bauer, H. -K.; Goetze, E. et al.
Materials and scaffolds in medical 3D printing and bioprinting in the context of bone regenerationINTERNATIONAL JOURNAL OF COMPUTERIZED DENTISTRY. Bd. 19. H. 4. 2016 S. 301-321
Van der Ven, H.; Liebenthron, J.; Beckmann, M. et al.
Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery ratesHUMAN REPRODUCTION. Bd. 31. H. 9. 2016 S. 2031-2041
Farthmann, Juliane; Hasenburg, Annette
Oncology Sexuality after gynecological oncology Cancer and Breast CancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 76. H. 3. 2016 S. 231-233
Schmidt, Marcus
Palbociclib - from Bench to Bedside and BeyondBREAST CARE. Bd. 11. H. 3. 2016 S. 177-181
Hilbert, F.; Gropp-Meier, M.; Schmalfeldt, B. et al.
Patient-reported outcome (PRO) results from the AGO-OVAR 2.20/ENGOT-ov14/PENELOPE double-blind placebo-controlled randomised phase III trial evaluating chemotherapy +/- pertuzumab for platinum-resistant ovarian cancer (PROC)ONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 138-138